| Name | Title | Contact Details |
|---|
Third Pole, Inc. is a US-based company developing next generation life-saving cardiopulmonary therapies. We are building on our team`s legacy in inhaled nitric oxide (NO), the current standard of care, to develop next generation life-saving heart and lung therapies.
IDS Limited is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of major depressive disorder (MDD). Neuralstem is expecting to launch a Phase II study for MDD in 2015. Neuralstem`s first stem cell therapy product, NSI-566, a spinal cord-derived neural stem cell line, is in ongoing clinical trials to treat amyotrophic lateral sclerosis (ALS, or Lou Gehrig`s disease), for which it has received orphan status designation by the FDA. Dosing in a phase IIa trial was completed in July, 2014. The next trial is anticipated to commence in 2015. In addition to ALS, the company is conducting an NSI-566 Phase I trial in chronic spinal cord injury, with NSI-566 clinical development also underway to treat ischemic
Apria Healthcare is one of the nation`s leading providers of home respiratory services and certain medical equipment, including oxygen therapy, inhalation therapies, sleep apnea treatment, and negative pressure wound therapy. Apria was the first such company to obtain voluntary accreditation from the Joint Commission and has been continuously accredited for more than 25 consecutive years. Apria operates more than 290 service locations throughout the United States and serves more than 2 million patients each year. In many cases, it`s a new beginning for its patients with the chance to return home from the hospital to resume their lives. What makes Apria industry leading is its focus on the patient as well as its employees. The people who work at Apria have passion and a commitment to excellence and we foster that compassion. Apria employees continually enhance their skills, receive training, and exhibit the kind of professionalism that makes Apria a highly effective and knowledgeable resource for our patients and healthcare customers.
Angelus Plaza is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.